Literature DB >> 7743668

Sequence analysis of the germ-line VH gene corresponding to a nephritogenic antibody in MRL/lpr lupus mice.

M Ono1, T Yamamoto, M Kyogoku, M Nose.   

Abstract

In order to investigate the genetic origin of nephritogenic antibodies in MRL/Mp-lpr/lpr (MRL/lpr) lupus mice, we isolated the germ-line heavy chain variable region (VH) gene corresponding to the nephritogenic antibody, B1, derived from an unmanipulated MRL/lpr mouse. Injection of this antibody into C.B-17/Icr-scid/scid mice resulted in the generation of wire loop-like glomerular lesions resembling those of lupus nephritis. Nucleotide sequences of this germ-line VH gene showed no replacement mutation in the VH region of the B1 antibody. Furthermore, this gene was identical to that found in the C3H/HeJ-lpr/lpr strain of mice. Our results suggest that germ-line VH genes can encode nephritogenic antibodies without somatic mutation, even in a mouse strain not prone to lupus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743668      PMCID: PMC1534343          DOI: 10.1111/j.1365-2249.1995.tb03666.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Boundaries of somatic mutation in rearranged immunoglobulin genes: 5' boundary is near the promoter, and 3' boundary is approximately 1 kb from V(D)J gene.

Authors:  S G Lebecque; P J Gearhart
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

2.  A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin.

Authors:  J Kavaler; A J Caton; L M Staudt; D Schwartz; W Gerhard
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

Review 3.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

4.  Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms.

Authors:  L Reininger; T Berney; T Shibata; F Spertini; R Merino; S Izui
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.

Authors:  R Orlandi; D H Güssow; P T Jones; G Winter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB x NZW)F1 mouse.

Authors:  T N Marion; D M Tillman; N T Jou
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

7.  Anti-peptide antibodies detect a lupus-related interspecies idiotype that maps to H chain CDR2.

Authors:  K Meek; M Takei; H Dang; I Sanz; M J Dauphinée; J D Capra; N Talal
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

8.  Possible deletion of a developmentally regulated heavy-chain variable region gene in autoimmune diseases.

Authors:  P M Yang; N J Olsen; K A Siminovitch; T Olee; F Kozin; D A Carson; P P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

9.  Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus.

Authors:  B P Tsao; F M Ebling; C Roman; N Panosian-Sahakian; K Calame; B H Hahn
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

10.  Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation.

Authors:  M Shlomchik; M Mascelli; H Shan; M Z Radic; D Pisetsky; A Marshak-Rothstein; M Weigert
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  1 in total

1.  Mapping an epitope in EBNA-1 that is recognized by monoclonal antibodies to EBNA-1 that cross-react with dsDNA.

Authors:  Pragya Yadav; Matthew T Carr; Ruby Yu; Alice Mumbey-Wafula; Linda A Spatz
Journal:  Immun Inflamm Dis       Date:  2016-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.